Cargando…
Predicted patient demand for a new delivery system for glaucoma medicine
Sustained-release drug delivery systems that replace the need for daily glaucoma medications will improve outcomes for those who are nonadherent and reduce the inconvenience of having to take medications on a recurring basis. The objective is to estimate uptake (i.e., demand) for a new technology th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403112/ https://www.ncbi.nlm.nih.gov/pubmed/28403115 http://dx.doi.org/10.1097/MD.0000000000006626 |